Abbott Laboratories buy Wells Fargo & Company
Start price
19.10.23
/
50%
€88.90
Target price
19.10.24
€109.69
Performance (%)
16.42%
Price
18:48
€102.48
Summary
This prediction is currently active. The prediction currently has a performance of 16.42%. Dividends of €1.02 are taken into consideration when calculating the performance. This prediction currently runs until 19.10.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.131% | 1.131% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Wells Fargo & Company from $136.00 to $116.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.86
05.04.23
05.04.23
€124.25
05.04.24
05.04.24
8.89%
06.04.24
06.04.24